Clinical risk factors for age-related macular degeneration: A systematic review and meta-analysis

BMC Ophthalmology

Volumn 10, Issue 1, 2010, Pages

  Chakravarthy, Usha ^a   Wong, Tien Y ^b,c   Fletcher, Astrid ^d   Piault, Elisabeth ^e   Evans, Christopher ^e   Zlateva, Gergana ^f   Buggage, Ronald ^g   Pleil, Andreas ^f   Mitchell, Paul ^h  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e MAPI VALUES   (United States)

^f PFIZER INC   (United States)

^g NOVARTIS PHARMA AG   (Switzerland)

^h UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

AGING; CARDIOVASCULAR DISEASE; CATARACT EXTRACTION; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; EYE COLOR; GENETIC PREDISPOSITION; HUMAN; META ANALYSIS; METABOLISM; METHODOLOGY; OBESITY; RACE; RETINA MACULA DEGENERATION; REVIEW; RISK; RISK FACTOR; SEX DIFFERENCE; SMOKING;

AGING; CARDIOVASCULAR DISEASES; CATARACT EXTRACTION; CONTINENTAL POPULATION GROUPS; DIABETES COMPLICATIONS; EVIDENCE-BASED MEDICINE; EYE COLOR; FIBRINOGEN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACULAR DEGENERATION; OBESITY; ODDS RATIO; RISK; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 78649936436     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-10-31     Document Type: Article

References (94)

1. Age-related macular degeneration is the leading cause of blindness. NM Bressler, JAMA 2004 291 1900 1 10.1001/jama.291.15.1900 15108691
2. Age related macular degeneration. U Chakravarthy, BMJ 2006 333 869 70 10.1136/bmj.39009.366736.80 17068017
3. Age-related macular degeneration. RD Jager WF Mieler JW Miller, N Engl J Med 2008 358 2606 17 10.1056/NEJMra0801537 18550876
4. The Wisconsin age-related maculopathy grading system. R Klein MD Davis YL Magli P Segal BE Klein L Hubbard, Ophthalmology 1991 98 1128 34 1843453
5. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. P Mitchell W Smith K Attebo JJ Wang, Ophthalmology 1995 102 1450 60 9097791
6. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Age-Related Eye Disease Study Research Group, Archives of Ophthalmology 2001 119 1417 36 11594942
7. The natural history and prognosis of neovascular age-related macular degeneration: A systematic review of the literature and meta-analysis. TY Wong U Chakravarthy R Klein P Mitchell G Zlateva R Buggage, et al. Ophthalmology 2008 115 116 26 10.1016/j.ophtha.2007.03.008 17675159
8. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. DM Brown PK Kaiser M Michels G Soubrane JS Heier RY Kim, et al. N Engl J Med 2006 355 1432 44 10.1056/NEJMoa062655 17021319
9. New treatments for neovascular acute macular degeneration. U Chakravarthy JI Lim, BMJ 2007 334 269 70 10.1136/bmj.39100.460671.BE 17289688
10. Ranibizumab for neovascular age-related macular degeneration. PJ Rosenfeld DM Brown JS Heier DS Boyer PK Kaiser CY Chung, et al. New England Journal of Medicine 2006 355 1419 31 10.1056/NEJMoa054481 17021318
11. Clinical update: new treatments for age-related macular degeneration. TY Wong G Liew P Mitchell, Lancet 2007 370 204 6 10.1016/S0140-6736(07)61104-0 17658379
12. Cigarette Smoking and Age-Related Macular Degeneration in the EUREYE Study. U Chakravarthy C Augood GC Bentham PT De Jong M Rahu J Seland, et al. Ophthalmology 2007 114 1157 63 10.1016/j.ophtha.2006.09.022 17337063
13. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. EW Chong TY Wong AJ Kreis JA Simpson RH Guymer, BMJ 2007 335 755 10.1136/bmj.39350.500428.47 17923720
14. Sunlight exposure, antioxidants, and age-related macular degeneration. AE Fletcher GC Bentham M Agnew IS Young C Augood U Chakravarthy, et al. Arch Ophthalmol 2008 126 1396 403 10.1001/archopht.126.10.1396 18852418
15. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. A Thakkinstian P Han M McEvoy W Smith J Hoh K Magnusson, et al. Hum Mol Genet 2006 15 2784 90 10.1093/hmg/ddl220 16905558
16. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.[erratum appears in Arch Ophthalmol. 2003 Jul;121(7):955]. R Van Leeuwen CC Klaver JR Vingerling A Hofman PT De Jong, Archives of Ophthalmology 2003 121 4 519 26 10.1001/archopht.121.4.519 12695249
17. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. EW Chong AJ Kreis TY Wong JA Simpson RH Guymer, Arch Ophthalmol 2008 126 826 33 10.1001/archopht.126.6.826 18541848
18. Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. EW Chong AJ Kreis TY Wong JA Simpson RH Guymer, Am J Ophthalmol 2008 145 707 15 10.1016/j.ajo.2007.12.005 18242575
19. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JM Seddon PJ Francis S George DW Schultz B Rosner ML Klein, JAMA 2007 297 1793 800 10.1001/jama.297.16.1793 17456821
20. Rapid dissection of the genetic risk of age-related macular degeneration: achieving the promise of the genomic era. JL Haines MA Pericak-Vance, JAMA 2007 297 401 2 10.1001/jama.297.4.401 17252632
21. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. DD Despriet CC Klaver JC Witteman AA Bergen I Kardys MP de Maat, et al. JAMA 2006 296 301 9 10.1001/jama.296.3.301 16849663
22. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. FL Ferris MD Davis TE Clemons LY Lee EY Chew AS Lindblad, et al. Archives of Ophthalmology 2005 123 1570 5174 10.1001/archopht.123.11.1570 16286620
23. An update on the genetics of age-related macular degeneration. HP Sholl M Fleckenstein IP Charbel C Keihauer FG Holz BH Weber, Mol Vis 2007 13 196 205 17327825
24. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. JJ Wang R Klein W Smith BE Klein S Tomany P Mitchell, Ophthalmology 2003 110 1960 7 10.1016/S0161-6420(03)00816-9 14522772
25. Risk factors for age-related macular degeneration: Pooled findings from three continents. W Smith J Assink R Klein P Mitchell CC Klaver BE Klein, et al. Ophthalmology 2001 108 697 704 10.1016/S0161-6420(00)00580-7 11297486
26. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. SC Tomany JJ Wang R Van Leeuwen R Klein P Mitchell JR Vingerling, et al. Ophthalmology 2004 111 1280 7 10.1016/j.ophtha.2003.11.010 15234127
27. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. H Buch NV Nielsen T Vinding GB Jensen JU Prause M la Cour, Ophthalmology 2005 112 787 98 10.1016/j.ophtha.2004. 11.040 15878058
28. Smoking, cardiovascular risk factors, and age-related macular degeneration in Asians: the Singapore Malay Eye Study. P Cackett TY Wong T Aung SM Saw WT Tay E Rochtchina, et al. Am J Ophthalmol 2008 146 960 7 10.1016/j.ajo.2008.06.026 18723144
29. Causes and prevalence of visual impairment among adults in the United States. N Congdon B O'Colmain CC Klaver R Klein B Munoz DS Friedman, et al. Archives of Ophthalmology 2004 122 477 85 10.1001/archopht.122.4.477 15078664
30. Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. R Kawasaki JJ Wang GJ Ji B Taylor T Oizumi M Daimon, et al. Ophthalmology 2008 115 1376 81 1381 10.1016/j.ophtha.2007.11.015 18222000
31. Prevalence of age-related macular degeneration in a Malay population: the Singapore Malay Eye Study. R Kawasaki JJ Wang T Aung DT Tan P Mitchell M Sandar, et al. Ophthalmology 2008 115 1735 41 10.1016/j.ophtha.2008.02.012 18439679
32. Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy. R Klein BE Klein MD Knudtson TY Wong A Shankar MY Tsai, Am J Ophthalmol 2005 140 35 44 15939388
33. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. H Buch T Vinding M la Cour GB Jensen JU Prause NV Nielsen, Acta Ophthalmologica Scandinavica 2005 83 409 18 10.1111/j.1600-0420. 2005.00492.x 16029262
34. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. WG Christen RJ Glynn JE Manson UA Ajani JE Buring, JAMA 1996 276 1147 51 10.1001/jama.276.14.1147 8827967
35. Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study. S Cugati P Mitchell E Rochtchina AG Tan W Smith JJ Wang, Ophthalmology 2006 113 2020 5 10.1016/j.ophtha.2006.05.047 16935334
36. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. DD Despriet CC Klaver JC Witteman AA Bergen I Kardys MP de Maat, et al. JAMA 2006 296 301 9 10.1001/jama.296.3.301 16849663
37. The relationship of ocular factors to the incidence and progression of age-related maculopathy. R Klein BE Klein SC Jensen KJ Cruickshanks, Archives of Ophthalmology 1998 116 506 13 9565051
38. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. R Klein BE Klein TY Wong SC Tomany KJ Cruickshanks, Archives of Ophthalmology 2002 120 1551 8 12427071
39. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. R Klein BE Klein SC Tomany SE Moss, American Journal of Epidemiology 2002 156 589 98 10.1093/aje/kwf092 12244027
40. Early age-related maculopathy in the cardiovascular health study. R Klein BE Klein EK Marino LH Kuller C Furberg GL Burke, et al. Ophthalmology 2003 110 25 33 10.1016/S0161-6420(02)01565-8 12511342
41. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. R Klein BE Klein MD Knudtson TY Wong MF Cotch K Liu, et al. Ophthalmology 2006 113 373 80 10.1016/j.ophtha.2005. 12.013 16513455
42. Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. MC Leske SY Wu A Hennis B Nemesure L Yang L Hyman, et al. Ophthalmology 2006 113 29 35 10.1016/j.ophtha.2005.08.012 16290049 (Pubitemid 43021724)
43. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. P Mitchell JJ Wang W Smith SR Leeder, Archives of Ophthalmology 2002 120 1357 63 12365915
44. Body mass index and the incidence of visually significant age-related maculopathy in men. DA Schaumberg WG Christen SE Hankinson RJ Glynn, Archives of Ophthalmology 2001 119 1259 65 11545630
45. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. JM Seddon J Cote N Davis B Rosner, Archives of Ophthalmology 2003 121 785 92 10.1001/archopht.121.6.785 12796248
46. Cardiovascular Risk Factors and the Long-term Incidence of Age-Related Macular Degeneration The Blue Mountains Eye Study. JS Tan P Mitchell W Smith JJ Wang, Ophthalmology 2007 114 1143 50 10.1016/j.ophtha.2006.09.033 17275090
47. The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. SC Tomany R Klein BE Klein ES Beaver Dam, Ophthalmology 2003 110 1526 33 10.1016/S0161-6420(03)00539-6 12917167
48. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.[erratum appears in Arch Ophthalmol. 2003 Jul;121(7):955]. R Van Leeuwen CC Klaver JR Vingerling A Hofman PT De Jong, Archives of Ophthalmology 2003 121 4 519 26 10.1001/archopht.121.4.519 12695249
49. Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals. T Vinding M Appleyard J Nyboe G Jensen, Acta Ophthalmologica (Copenhagen) 1992 70 66 72 10.1111/j.1755-3768.1992.tb02093.x
50. Phacoemulsification does not induce neovascular age-related macular degeneration. H Baatz R Darawsha H Ackermann GB Scharioth D de Ortueta M Pavlidis, et al. Invest Ophthalmol Vis Sci 2008 49 1079 83 10.1167/iovs.07-0557 18326733
51. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l'Age. C Delcourt JL Diaz A Ponton-Sanchez L Papoz, Archives of Ophthalmology 1998 116 1031 5 9715683
52. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. C Delcourt F Michel A Colvez A Lacroux M Delage MH Vernet, Ophthalmic Epidemiology 2001 8 237 49 10.1076/opep.8.4.237.1613 11471092
53. Sociodemographic factors and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. S Fraser-Bell J Donofrio J Wu R Klein SP Azen R Varma, et al. American Journal of Ophthalmology 2005 139 30 8 10.1016/j.ajo.2004.08.029 15652825
54. Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study. S Fraser-Bell J Wu R Klein SP Azen C Hooper AW Foong, et al. Am J Ophthalmol 2008 145 308 16 10.1016/j.ajo.2007.10.007 18222193
55. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies.[see comment]. EE Freeman B Munoz SK West JM Tielsch OD Schein, American Journal of Ophthalmology 2003 135 6 849 56 10.1016/S0002-9394(02)02253-5 12788126
56. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study.[see comment]. R Klein BE Klein T Franke, Ophthalmology 1993 100 3 406 14 8460013
57. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. R Klein BE Klein KL Linton DL DeMets, American Journal of Epidemiology 1993 137 190 200 8452123 (Pubitemid 23083671)
58. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. R Klein BE Klein SC Jensen JA Mares-Perlman KJ Cruickshanks M Palta, Ophthalmology 1999 106 1056 65 10.1016/S0161-6420(99)90255-5 10366071
59. Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. R Klein MD Knudtson BE Klein TY Wong MF Cotch K Liu, et al. Ophthalmology 2008 115 1742 9 10.1016/j.ophtha.2008.03. 021 18538409
60. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. W Smith P Mitchell SR Leeder JJ Wang, Archives of Ophthalmology 1998 116 583 7 9596493
61. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. R Varma S Fraser-Bell S Tan R Klein SP Azen Los Angeles Latino Eye Study Group, Ophthalmology 2004 111 1288 97 10.1016/j.ophtha.2004.01.023 15234128
62. Age-related macular degeneration and smoking. The Rotterdam Study. JR Vingerling A Hofman DE Grobbee PT De Jong, Archives of Ophthalmology 1996 114 1193 6 8859077
63. Cataract and age-related maculopathy: the Blue Mountains Eye Study. JJ Wang PG Mitchell RG Cumming R Lim, Ophthalmic Epidemiology 1999 6 317 26 10.1076/opep.6.4.317.4182 10544345
64. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Age-Related Eye Disease Study Research Group, Ophthalmology 2000 107 2224 32 10.1016/S0161-6420(00)00409-7 11097601
65. Risk factors in age-related maculopathy complicated by choroidal neovascularization. MS Blumenkranz SR Russell MG Robey R Kott-Blumenkranz N Penneys, Ophthalmology 1986 93 552 8 2425325
66. Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group. G Chaine A Hullo J Sahel G Soubrane MA Espinasse-Berrod D Schutz, et al. British Journal of Ophthalmology 1998 82 996 1002 10.1136/bjo.82.9.996 9893587
67. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. RE Hogg JV Woodside SE Gilchrist R Graydon AE Fletcher W Chan, et al. Ophthalmology 2008 115 1046 52 10.1016/j.ophtha.2007.07. 031 17953990
68. Senile macular degeneration: a case-control study. LG Hyman AM Lilienfeld FL Ferris III SL Fine, American Journal of Epidemiology 1983 118 213 27 6881127
69. Genetic risk of age-related maculopathy. Population-based familial aggregation study. CC Klaver RC Wolfs JJ Assink CM van Duijn A Hofman PT De Jong, Archives of Ophthalmology 1998 116 1646 51 9869796
70. Smoking and neovascular form of age related macular degeneration in late middle aged males: findings from a case-control study in Japan. Research Committee on Chorioretinal Degenerations. A Tamakoshi M Yuzawa M Matsui M Uyama NK Fujiwara Y Ohno, British Journal of Ophthalmology 1997 81 901 4 10.1136/bjo.81.10.901 9486034
71. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies.[see comment]. EE Freeman B Munoz SK West JM Tielsch OD Schein, American Journal of Ophthalmology 2003 135 6 849 56 10.1016/S0002-9394(02)02253-5 12788126
72. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study.[see comment]. R Klein BE Klein T Franke, Ophthalmology 1993 100 3 406 14 8460013
73. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.[erratum appears in Arch Ophthalmol. 2003 Jul;121(7):955]. R Van Leeuwen CC Klaver JR Vingerling A Hofman PT De Jong, Archives of Ophthalmology 2003 121 4 519 26 10.1001/archopht.121.4.519 12695249
74. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. R Varma M Ying-Lai BA Francis BB Nguyen J Deneen MR Wilson, et al. Ophthalmology 2004 111 1439 48 10.1016/j.ophtha.2004.01.025 15288969
75. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.[erratum appears in Arch Ophthalmol. 2003 Jul;121(7):955]. R Van Leeuwen CC Klaver JR Vingerling A Hofman PT De Jong, Archives of Ophthalmology 2003 121 4 519 26 10.1001/archopht.121.4.519 12695249
76. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study.[republished in Ophthalmology. 2003 Jun;110(6):1273-80; PMID: 12799274]. R Klein BE Klein SC Tomany KJ Cruickshanks, Ophthalmology 2003 110 4 636 43 10.1016/S0161-6420(02) 01448-3 12689879
77. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies.[see comment]. EE Freeman B Munoz SK West JM Tielsch OD Schein, American Journal of Ophthalmology 2003 135 6 849 56 10.1016/S0002-9394(02)02253-5 12788126
78. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies.[see comment]. EE Freeman B Munoz SK West JM Tielsch OD Schein, American Journal of Ophthalmology 2003 135 6 849 56 10.1016/S0002-9394(02)02253-5 12788126
79. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. R Klein BE Klein KL Linton, Ophthalmology 1992 99 933 43 1630784
80. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study.[republished in Ophthalmology. 2003 Jun;110(6):1273-80; PMID: 12799274]. R Klein BE Klein SC Tomany KJ Cruickshanks, Ophthalmology 2003 110 4 636 43 10.1016/S0161-6420(02) 01448-3 12689879
81. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study.[see comment]. R Klein BE Klein T Franke, Ophthalmology 1993 100 3 406 14 8460013
82. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study.[see comment]. R Klein BE Klein T Franke, Ophthalmology 1993 100 3 406 14 8460013
83. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JM Seddon PJ Francis S George DW Schultz B Rosner ML Klein, JAMA 2007 297 1793 800 10.1001/jama.297.16.1793 17456821
84. Rapid dissection of the genetic risk of age-related macular degeneration: achieving the promise of the genomic era. JL Haines MA Pericak-Vance, JAMA 2007 297 401 2 10.1001/jama.297.4.401 17252632
85. Complement component C3 and risk of age-related macular degeneration. DD Despriet CM van Duijn BA Oostra AG Uitterlinden A Hofman AF Wright, et al. Ophthalmology 2009 116 474 80 10.1016/j.ophtha.2008.09.055 19168221
86. Complement C3 variant and the risk of age-related macular degeneration. JR Yates T Sepp BK Matharu JC Khan DA Thurlby H Shahid, et al. N Engl J Med 2007 357 553 61 10.1056/NEJMoa072618 17634448
87. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. J Goldberg G Flowerdew E Smith JA Brody MO Tso, American Journal of Epidemiology 1988 128 700 10 3421236
88. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JM Seddon UA Ajani RD Sperduto R Hiller N Blair TC Burton, et al. JAMA 1994 272 1413 20 10.1001/jama.272.18.1413 7933422
89. Neovascular age-related macular degeneration and its relationship to antioxidant intake. EL Snellen AL Verbeek GW Van Den Hoogen JR Cruysberg CB Hoyng, Acta Ophthalmologica Scandinavica 2002 80 4 368 71 10.1034/j.1600-0420. 2002.800404.x 12190777
90. Population-based studies in ophthalmology. TY Wong L Hyman, Am J Ophthalmol 2008 146 656 63 10.1016/j.ajo.2008.07.048 18984085
91. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies.[see comment]. EE Freeman B Munoz SK West JM Tielsch OD Schein, American Journal of Ophthalmology 2003 135 6 849 56 10.1016/S0002-9394(02)02253-5 12788126
92. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study.[see comment]. R Klein BE Klein T Franke, Ophthalmology 1993 100 3 406 14 8460013
93. Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER. B Munoz R Klein J Rodriguez R Snyder SK West, Archives of Ophthalmology 2005 123 1575 80 10.1001/archopht.123.11.1575 16286621
94. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.[erratum appears in Arch Ophthalmol. 2003 Jul;121(7):955]. R Van Leeuwen CC Klaver JR Vingerling A Hofman PT De Jong, Archives of Ophthalmology 2003 121 4 519 26 10.1001/archopht.121.4.519 12695249